An article today in Reuters announced that Humira has been approved for the treatment of juvenile rheumatoid arthritis.
“Abbott said the U.S. Food and Drug Administration has approved use of the medicine, its best-selling product, to treat patients four years of age and older with moderate to severe rheumatoid arthritis. Patients will receive injections once every two weeks.”
I’ve gotten a lot of relief from using Humira, so I am excited that it may help those diagnosed with JRA as well. According to the article, there are about 50,000 Americans, so that means there are a lot of kids that can benefit from using a biologic. I think this is great since biologics such as Humira help to prevent erosion of the joints caused by the disease. When you get the disease at such a young age, you have a lot of time for erosion to occur. To get a jump start on preventing any erosion is great.
Until next time,
S.P.
Leave a Comment